From the press release archive
Medicine 2021-02-03 1 min read

COVID-19 vaccination for patients with Parkinson's disease recommended

Experts writing in the Journal of Parkinson's disease stress the benefits, efficacy and safety profile of the COVID-19 vaccines for this specific patient population
Published 2021-02-03 · Original archive entry · Explore research explainers
Amsterdam, NL, February 3, 2021 - Patients with Parkinson's disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment. In a END
From the original Press-News collection. Issuers of news releases are responsible for the accuracy of their content.